BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27864108)

  • 1. Biopsy Perineural Invasion in Prostate Cancer Patients Who Are Candidates for Active Surveillance by Strict and Expanded Criteria.
    Turner RM; Yecies TS; Yabes JG; Ristau BT; Woldemichael E; Davies BJ; Jacobs BL; Nelson JB
    Urology; 2017 Apr; 102():173-177. PubMed ID: 27864108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perineural invasion in prostate needle biopsy: Prognostic value on radical prostatectomy and active surveillance.
    Ramos N; Macedo A; Rosa J; Carvalho M
    Arch Ital Urol Androl; 2020 Dec; 92(4):. PubMed ID: 33348961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perineural invasion in prostate cancer patients who are potential candidates for active surveillance: validation study.
    Trpkov C; Yilmaz A; Trpkov K
    Urology; 2014 Jul; 84(1):149-52. PubMed ID: 24976227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy.
    DeLancey JO; Wood DP; He C; Montgomery JS; Weizer AZ; Miller DC; Jacobs BL; Montie JE; Hollenbeck BK; Skolarus TA
    Urology; 2013 Feb; 81(2):354-7. PubMed ID: 23374801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perineural invasion on prostate biopsy does not predict adverse pathological outcome.
    Elharram M; Margel D; Finelli A; Trachtenberg J; Evans A; van der Kwast TH; Sweet JM; Fleshner N
    Can J Urol; 2012 Dec; 19(6):6567-72. PubMed ID: 23228294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanded criteria to identify men eligible for active surveillance of low risk prostate cancer at Johns Hopkins: a preliminary analysis.
    Reese AC; Landis P; Han M; Epstein JI; Carter HB
    J Urol; 2013 Dec; 190(6):2033-8. PubMed ID: 23680308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of biopsy perineural invasion on the outcomes of patients who underwent radical prostatectomy: a systematic review and meta-analysis.
    Wu S; Lin X; Lin SX; Lu M; Deng T; Wang Z; Olumi AF; Dahl DM; Wang D; Blute ML; Wu CL
    Scand J Urol; 2019 Oct; 53(5):287-294. PubMed ID: 31401922
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigating association of perineural invasion on prostate biopsy with Gleason score upgrading at prostatectomy: A multi-institutional analysis.
    Barsky AR; Kraus RD; Carmona R; Santos PMG; Li C; Schwartz LE; Ballas LK; Vapiwala N
    Cancer Med; 2020 May; 9(10):3383-3389. PubMed ID: 32187859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate biopsy perineural invasion is not independently associated with positive surgical margins following radical retropubic prostatectomy.
    Ristau BT; Tomaszewski JJ; Chen YF; Bertolet M; Woldemichael E; Nelson JB
    World J Urol; 2015 Sep; 33(9):1269-74. PubMed ID: 25366883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma.
    Rubin MA; Bassily N; Sanda M; Montie J; Strawderman MS; Wojno K
    Am J Surg Pathol; 2000 Feb; 24(2):183-9. PubMed ID: 10680885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopsy Core Features are Poor Predictors of Adverse Pathology in Men with Grade Group 1 Prostate Cancer.
    Audenet F; Vertosick EA; Fine SW; Sjoberg DD; Vickers AJ; Reuter VE; Eastham JA; Scardino PT; Touijer KA
    J Urol; 2018 Apr; 199(4):961-968. PubMed ID: 29030317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of perineural invasion in prostate needle biopsy on tumor grade and biochemical recurrence rates after radical prostatectomy.
    Celik S; Bozkurt O; Demir O; Gurboga O; Tuna B; Yorukoglu K; Aslan G
    Kaohsiung J Med Sci; 2018 Jul; 34(7):385-390. PubMed ID: 30063011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens.
    Maru N; Ohori M; Kattan MW; Scardino PT; Wheeler TM
    Hum Pathol; 2001 Aug; 32(8):828-33. PubMed ID: 11521227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of biopsy perineural invasion on long-term biochemical disease-free survival after radical prostatectomy.
    O'Malley KJ; Pound CR; Walsh PC; Epstein JI; Partin AW
    Urology; 2002 Jan; 59(1):85-90. PubMed ID: 11796287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of perineural invasion and race in men considering active surveillance.
    Cohn JA; Dangle PP; Wang CE; Brendler CB; Novakovic KR; McGuire MS; Helfand BT
    BJU Int; 2014 Jul; 114(1):75-80. PubMed ID: 24106869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a "low-risk" cohort of grade group 2 prostate cancer patients: Results from the Shared Equal Access Regional Cancer Hospital database.
    McGinley KF; Sun X; Howard LE; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Freedland SJ
    Int J Urol; 2017 Aug; 24(8):611-617. PubMed ID: 28589550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perineural invasion is a marker for pathologically advanced disease in localized prostate cancer.
    Lee IH; Roberts R; Shah RB; Wojno KJ; Wei JT; Sandler HM
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1059-64. PubMed ID: 17398032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Volume on Biopsy of Low Risk Prostate Cancer Managed with Active Surveillance.
    Tosoian JJ; Mamawala M; Patel HD; Alam R; Epstein JI; Ross AE; Carter HB
    J Urol; 2018 Apr; 199(4):954-960. PubMed ID: 29074222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitive pathology at radical prostatectomy is commonly favorable in men following initial active surveillance.
    Hong SK; Sternberg IA; Keren Paz GE; Kim PH; Touijer KA; Scardino PT; Eastham JA
    Eur Urol; 2014 Aug; 66(2):214-9. PubMed ID: 23954083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perineural invasion on biopsy is associated with upstaging at radical prostatectomy in Gleason score 3 + 4 = 7 prostate cancer.
    Flood TA; Schieda N; Keefe DT; Morash C; Bateman J; Mai KT; Belanger EC; Robertson SJ; Breau RH
    Pathol Int; 2016 Nov; 66(11):629-632. PubMed ID: 27709739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.